Company Profile
Cisbio Bioassays is a privately held life sciences company committed to improving human healthcare. With more than 30 years of experience in in vitro diagnostics and drug discovery, we provide creative technological solutions and partnerships to the global scientific community. Our portfolio of over 460 proprietary assays and reagents is used by pharmaceutical, biotechnology, academia and contract research organizations worldwide to help generate effective therapies.
Reviews
- Ease of use
- After sales service
- Value for money
"A universal Ser/Thr HTRF kinase assay."
Mohammed Kashem
‘Membership Status’ indicates whether this member is an active reviewer on the site, and how many reviews have been published.| Status: | No. Reviews Published: |
| Member | 0 |
Reviewer | 1-4 |
| Advanced Reviewer | 5-14 |
| Expert Reviewer | 15+ |
To be seen as an authority on SelectScience, find your products to review today., Boehringer Ingelheim
Latest Videos
Latest news
News
Cisbio to Display Newest Innovations for Oncology Drug Discovery at AACR 2014
20 Mar 2014
-
Cisbio Bioassays Launches Epigenetics Toolbox
25 Sep 2012
-
Cisbio Bioassays Now Offers Function and Binding Tools to Investigate All Muscarinic Receptors
16 Jun 2011
-
Cisbio Bioassays and IGF Launch Project to Facilitate CNS Target Drug Discovery
30 Nov 2010
-
New Flexible Tool for Cell Surface Receptor Heterodimerization
22 Sep 2010
Application articles
-
Deciphering the Mechanism of Action of Drugs Targeting EGFR, by Cisbio’s Advanced Cell-Based Pathway Readout Assays
Cisbio Bioassays26 Sep 2014
-
Enabling Epigenetics Studies from HTS to SAR: a Novel HTRF® Platform to Identify and Characterize Reader Domain Inhibitors
Cisbio Bioassays24 Sep 2014
-
HTRF® Assays for Diabetes Investigation
Cisbio Bioassays10 Sep 2014
-
New Europium Cryptates to Probe Molecular Interactions using HTRF®
Cisbio Bioassays12 Mar 2010
-
Comparison of HTRF® Indirect Systems for Mouse and Rat Monoclonal Antibody Detection
Cisbio Bioassays05 Mar 2010
